These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study. Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951 [TBL] [Abstract][Full Text] [Related]
8. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. Devos D; Krystkowiak P; Clement F; Dujardin K; Cottencin O; Waucquier N; Ajebbar K; Thielemans B; Kroumova M; Duhamel A; Destée A; Bordet R; Defebvre L J Neurol Neurosurg Psychiatry; 2007 May; 78(5):470-5. PubMed ID: 17098845 [TBL] [Abstract][Full Text] [Related]
9. Gait and attentional performance in freezers under methylphenidate. Delval A; Moreau C; Bleuse S; Guehl D; Bestaven E; Guillaud E; Dujardin K; Defebvre L; Devos D Gait Posture; 2015 Feb; 41(2):384-8. PubMed ID: 25468682 [TBL] [Abstract][Full Text] [Related]
10. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Okun MS; Gallo BV; Mandybur G; Jagid J; Foote KD; Revilla FJ; Alterman R; Jankovic J; Simpson R; Junn F; Verhagen L; Arle JE; Ford B; Goodman RR; Stewart RM; Horn S; Baltuch GH; Kopell BH; Marshall F; Peichel D; Pahwa R; Lyons KE; Tröster AI; Vitek JL; Tagliati M; Lancet Neurol; 2012 Feb; 11(2):140-9. PubMed ID: 22239915 [TBL] [Abstract][Full Text] [Related]
11. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Ferraye MU; Debû B; Fraix V; Goetz L; Ardouin C; Yelnik J; Henry-Lagrange C; Seigneuret E; Piallat B; Krack P; Le Bas JF; Benabid AL; Chabardès S; Pollak P Brain; 2010 Jan; 133(Pt 1):205-14. PubMed ID: 19773356 [TBL] [Abstract][Full Text] [Related]
13. Nigral stimulation for resistant axial motor impairment in Parkinson's disease? A randomized controlled trial. Weiss D; Walach M; Meisner C; Fritz M; Scholten M; Breit S; Plewnia C; Bender B; Gharabaghi A; Wächter T; Krüger R Brain; 2013 Jul; 136(Pt 7):2098-108. PubMed ID: 23757762 [TBL] [Abstract][Full Text] [Related]
14. Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial. Hauser RA; Olanow CW; Kieburtz KD; Pourcher E; Docu-Axelerad A; Lew M; Kozyolkin O; Neale A; Resburg C; Meya U; Kenney C; Bandak S Lancet Neurol; 2014 Aug; 13(8):767-76. PubMed ID: 25008546 [TBL] [Abstract][Full Text] [Related]
15. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study. Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010 [TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262 [TBL] [Abstract][Full Text] [Related]
17. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021 [TBL] [Abstract][Full Text] [Related]
18. Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial. Ferreira JJ; Lees A; Rocha JF; Poewe W; Rascol O; Soares-da-Silva P; Lancet Neurol; 2016 Feb; 15(2):154-165. PubMed ID: 26725544 [TBL] [Abstract][Full Text] [Related]
19. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Yamada K; Goto S; Hamasaki T; Kuratsu JI Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial. LeWitt PA; Hauser RA; Pahwa R; Isaacson SH; Fernandez HH; Lew M; Saint-Hilaire M; Pourcher E; Lopez-Manzanares L; Waters C; Rudzínska M; Sedkov A; Batycky R; Oh C; Lancet Neurol; 2019 Feb; 18(2):145-154. PubMed ID: 30663606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]